Calidi Biotherapeutics, Inc.
CLDI · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9,169 | $24,220 | $86,149 | $280,909 |
| - Cash | $9,591 | $2,049 | $372 | $1,063 |
| + Debt | $7,036 | $7,236 | $5,988 | $5,181 |
| Enterprise Value | $6,614 | $29,407 | $91,765 | $285,028 |
| Revenue | $0 | $0 | $45 | $449 |
| % Growth | – | -100% | -90% | – |
| Gross Profit | $0 | -$1,256 | -$229 | $355 |
| % Margin | – | – | -508.9% | 79.1% |
| EBITDA | -$19,727 | -$24,195 | -$24,998 | -$9,450 |
| % Margin | – | – | -55,551.1% | -2,104.7% |
| Net Income | -$22,143 | -$29,216 | -$25,427 | -$10,933 |
| % Margin | – | – | -56,504.4% | -2,435% |
| EPS Diluted | -35.7 | -207.61 | -358.8 | 14.16 |
| % Growth | 82.8% | 42.1% | -2,633.9% | – |
| Operating Cash Flow | -$19,694 | -$26,983 | -$13,214 | -$7,774 |
| Capital Expenditures | -$16 | -$585 | -$428 | -$206 |
| Free Cash Flow | -$19,710 | -$27,568 | -$13,642 | -$7,980 |